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Abstract 
Sleep disturbance is common among individuals at risk of psychosis, yet few studies have 
investigated the relationship between sleep disturbance and clinical trajectory. The Early 
Detection and Intervention Evaluation (EDIE-2) trial provides longitudinal data on sleep 
duration and individual psychotic experiences from a cohort of individuals at risk of psychosis, 
which this study utilises in an opportunistic secondary analysis. Shorter and more variable 
sleep was hypothesised to be associated with more severe psychotic experiences and lower 
psychological wellbeing. Mixed effect models were used to test sleep duration and range as 
predictors of individual psychotic experiences and psychological wellbeing over the 12-24 
months (with assessments every 3 months) in 160 participants. Shorter sleep duration was 
associated with more severe delusional ideas and hallucinations cross-sectionally and 
longitudinally. The longitudinal relationships did not remain significant after conservative 
controls were added for the previous severity of psychotic experiences. No significant 
relationships were found between the sleep variables and other psychotic experiences (e.g. 
cognitive disorganisation), or psychological wellbeing. The results support a relationship 
between shorter sleep duration and delusional ideas and hallucinations. Future studies should 
focus on improving sleep disturbance measurement, and test whether treating sleep improves 
clinical trajectory in the at-risk group.  
Keywords: At risk; sleep; psychosis; longitudinal
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1 Introduction 
A causal role for sleep disturbance in contributing to psychotic experiences has recently begun 
to emerge (Reeve et al., 2015). It has been demonstrated that reducing sleep increases 
psychotic experiences (Reeve et al., 2017), and that treating insomnia improves psychotic 
experiences (Freeman et al., 2017). Sleep disorders have also been shown to be common and 
severe, but treatable, among individuals with psychotic disorders (Freeman et al., 2015, 2009). 
However there has been a surprising lack of research specifically investigating the causal 
contribution of sleep disturbance to psychotic experiences in at-risk individuals (Davies et al., 
2016; Reeve et al., 2015; Zanini et al., 2013). This is despite a longstanding clinical awareness of 
sleep disturbance as a risk indicator for transition from the at-risk state to psychosis (Keshavan 
et al., 2004; Ruhrmann et al., 2010) 
Existing research does indicate that sleep abnormalities are common in individuals at-risk of 
psychosis. Between 37% and 78% of this population have been found to report sleep 
disturbance, as assessed on the Scale of Assessment of Positive Symptoms (SAPS) across several 
studies(Miller et al., 2003; Poe et al., 2017). Reporting sleep disturbance has also been found to 
be highly predictive of transition to psychotic episode in the following 18 month period 
(Ruhrmann et al., 2010). However, ‘sleep disturbance’ is a broad term comprising a range of 
sleep disorders and disturbances (e.g. insomnia, circadian rhythm disruption, nightmares). This 
in turn hinders further research on how sleep disturbance in this group may contribute to 
psychotic experiences or transition to psychosis, or how it may be clinically addressed. In 
contrast, sleep recording studies have identified a range of specific sleep abnormalities in 
individuals at-risk of psychosis, including longer sleep onset latency, reduced sleep efficiency, 
and increased circadian rhythm disturbance in comparison to non-clinical controls (Lunsford-
Avery et al., 2015; Zanini et al., 2015). These objective sleep disturbances have been linked with 
increased positive symptoms both at baseline and at 12 month follow up (Lunsford-Avery et al., 
2016, 2015). In summary, research to date supports that sleep disturbance is common and 
relevant to clinical trajectory in psychosis, yet there needs to be further consensus on which 
sleep variables are relevant in this relationship. Especially valuable would be identification of 
specific self-reported sleep disturbances that are predictive of psychotic experiences, given the 
lack of access to objective sleep recording measures in standard clinical services.  
One shortcoming across this literature has been the measurement of psychosis; in all the studies 
discussed above individual psychotic experiences were grouped together under the 
measurement of positive symptoms. However, multiple sources of evidence indicate that 
paranoia, hallucinations, grandiosity, and cognitive disorganisation exist as independent 
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continua in the population with somewhat differing risk, development, and maintenance factors 
(Ronald, 2015; van Os, 2014; Zavos et al., 2014). Furthermore, as reported in a recent 
experimental study, sleep loss affects the dimensions of psychotic experience differently, with 
significant effects on hallucinations, paranoia, and cognitive disorganisation, but no effect on 
grandiosity (Reeve et al., 2017). Therefore, measuring individual psychotic experience 
dimensions may allow a clearer picture to emerge of the relationships between sleep 
disturbance and psychotic experiences in the at-risk population.  
1.1 The Early Detection and Intervention Evaluation Trial (EDIE-2) 
The EDIE-2 trial data may provide an opportunity to address some of these issues. EDIE-2 was a 
multi-site randomised controlled trial of a psychological intervention aiming to reduce 
transition to psychosis (Morrison et al., 2012, 2011). A large cohort of individuals at risk for 
psychosis (n=288) were recruited from five sites in the UK, and randomised such that half 
received cognitive therapy based intervention and monitoring of mental state, and the other 
half received monitoring only. The intervention provided was based on a published treatment 
manual, and focused on psychotic experiences, although individual goals and formulations 
would have varied (French and Morrison, 2004). The cognitive therapy based intervention plus 
monitoring was significantly better than monitoring only in reducing severity of psychotic 
experiences, but not in reducing distress or transition to psychosis over 12 to 24 months 
(Morrison et al., 2012). 
Most relevant for current purposes, one of the questionnaires assessed time spent asleep on 
‘good’ and ‘bad’ nights over the previous three months. This provides a measure of sleep 
duration, alongside an indirect metric of the quality and variability of sleep by contrasting the 
‘good’ and ‘bad’ duration – thereby allowing sleep reporting beyond endorsement of general 
sleep disturbance. As study assessments were carried out every three months for a minimum of 
12 months (and up to 24 months), the EDIE-2 dataset has the most assessment time points, and 
longest follow up period, of any study recording sleep in the at-risk population to date. 
Furthermore, the assessment of psychotic experiences was carried out using the 
Comprehensive Assessment of At Risk Mental States (CAARMS), in which the subscales of the 
‘positive psychotic experiences’ dimension allow measurement of individual psychotic 
experiences (Yung et al., 2003). These design characteristics support the use of this dataset for 
an opportunistic secondary analysis of the relationship between sleep and individual psychotic 
experiences over time in the at-risk group. 
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1.2 The current study 
This study focuses on a secondary analysis of the EDIE-2 trial dataset with the aim of testing if 
sleep disturbance is significantly associated with more severe individual psychotic experiences 
cross-sectionally and longitudinally in a cohort of individuals at-risk of psychosis. A secondary 
aim was to test if sleep disturbance was cross-sectionally associated with depression or lower 
quality of life in this group. 
Sleep disturbance in this study is operationalised by using the ‘bad night’ sleep duration and the 
difference (i.e. range) between the ‘bad night’ and ‘good night’ sleep duration, as recorded in the 
EDIE-2 study time use measure. The expectation is that a shorter bad night sleep duration and 
larger range of sleep duration suggest secondary aspects of sleep disturbance from sleep 
disorders. For example, insomnia would be associated with short sleep duration, and often high 
variability (as individuals oversleep to catch up on sleep lost on bad nights). Circadian rhythm 
disorders would also typically be associated with high variability, and possible short duration, 
as the preferred sleep window clashes with daily commitments. 
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2 Method 
2.1 Participants 
Two hundred and eighty-eight individuals aged 14-35 years participated in the EDIE-2 trial. 
Participants were assessed with the CAARMS to confirm they fulfilled the inclusion criterion of 
being at-risk of psychosis (intermittent psychotic symptoms, attenuated psychotic symptoms, 
or a decline in functioning alongside having a first degree relative with psychotic disorder). 
Exclusion criteria included current or previous receipt of antipsychotic medication, moderate to 
severe learning disability, organic impairment, and insufficient fluency in English. Half of the 
participants were assigned to cognitive therapy plus monitoring of mental state and the other 
half to monitoring of mental state only. All participants were followed up for a minimum of 12 
months and a maximum of 24 months. For full details of trial design and results see Morrison et 
al. (2011, 2012). 
Sleep duration data were not retrievable from the Birmingham (n=60) or Cambridge (n=20) 
trial sites. Participants without a time point where both good sleep and bad sleep duration data 
had been reported were also excluded (n=48). This resulted in a final sample of 160 individuals 
for the current study.  
2.2 Measures 
2.2.1 Sleep 
Self-reported sleep duration on ‘good’ and ‘bad’ nights over the past three months was collected 
within the Economic Patient Questionnaire interview (developed from the Time Use Survey; 
Short, 2006). Participants estimated their average sleep duration on ‘good’ and ‘bad’ nights over 
the last three months. The bad night sleep duration, and the range of sleep duration (i.e. the 
difference between the good and bad night sleep durations) were used in the current study. 
This information was collected at baseline, 3, 6, 9, 12, 15, 18, 21, and 24 months. 
2.2.2 Psychotic experiences 
The CAARMS (Yung et al., 2003) was the primary measure of psychotic experiences in the EDIE-
2 trial. The positive dimension was used in the current study, which comprises four psychotic 
experience subscales: Unusual Thought Content (UTC; e.g. ideas of reference, delusional mood, 
thought insertion), Non-Bizarre Ideas (NBI; e.g. persecutory ideas, grandiose ideas), Perceptual 
Abnormalities (PA; e.g. visual or auditory changes) and Disorganised Speech (DS; e.g. 
circumstantial or tangential speech).  
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Each subscale is rated by the interviewer for severity (0 to 6 scale, where 0 is not present and 6 
is a clinical psychosis level), frequency and duration (0 to 6 scale, where 0 is absent, and 6 is 
continuous), and distress (0 to 100 scale, where 0 is not at all distressed, and 100 is extremely 
distressed). The severity and frequency are multiplied together to make a total severity score 
for the dimension. The individual distress scores are averaged to produce an overall distress 
score. Higher scores in all dimensions indicate greater severity, with scores ranging from 0 to 36 
for the severity subscales and 0 to 100 for the distress subscale. CAARMS data from the baseline, 
3, 6, 9, 12, 15, 18, 21, and 24 month assessments were used in the current study. 
2.2.3 Depression and Quality of Life 
Depression was assessed using the Beck Depression Inventory for Primary Care (BDI-PC; Beck 
et al., 1997). This is a self-report questionnaire comprising 7 statements, rated on a 0 to 3 scale 
(where 0 is “Did not apply to me”, and 3 is “Applied to me very much or all the time”). The 
overall score is the sum of these items, of which the maximum score is 21. The BDI-PC was 
completed at baseline, 6 months, and 12 months.  
The Manchester Short Assessment of Quality of Life (MANSA; Priebe et al., 1999) was used to 
measure satisfaction and quality of life. The measure comprises 12 items in which the 
participant assesses satisfaction in domains such as quality of friendships, financial situation, 
and physical health. Each item is rated on a 1 to 7 scale where 1 is a negative extreme (“Couldn’t 
be worse”), and 7 is a positive extreme (“Couldn’t be better”). The lowest possible score is 12, 
and the highest possible score is 84, with higher scores indicating increased satisfaction and 
higher quality of life. The MANSA was completed at baseline, 6 months and 12 months. 
2.3 Analysis 
All analyses were carried out using SPSS version 23 (IBM Corp., 2015). First, descriptive 
statistics were calculated for all study measures, and used to observe trends over the study. 
Differences between treatment allocation groups for each study measure (from all time points 
post-baseline) were then tested in independent samples t-tests. 
The primary analysis approach was to run a set of pre-specified stepped linear mixed effects 
models to address each of the study hypotheses, as listed below. All models were tested even if 
no relationship was found at a prior phase. Linear mixed effects models allow examination of 
within subject correlations cross-sectionally and longitudinally by nesting the observations 
within individuals and time points, and allow use of all available data under the assumption that 
data are missing at random. The threshold for significance was set at p≤0.05 for all analyses. 
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Site and treatment allocation were included as factors in all models. A diagram of the analysis 
process can be found in Figure 1.  
2.3.1 Hypothesis 1: Shorter ‘Bad night’ sleep duration and wider range in sleep duration 
will be associated with more severe psychotic experiences  
Models were fitted to each dimension of the CAARMS (UTC, NBI, PA, DS, and Distress) with bad 
night sleep duration and sleep duration range as factors to test this cross-sectional hypothesis. 
2.3.2 Hypothesis 2: Previous shorter ‘Bad night’ sleep duration and wider range in sleep 
duration will predict later psychotic experience severity 
This hypothesis was tested in several stages as below, with each stage acting as an increasingly 
conservative framing of the hypothesis via addition of control variables.  
Step 1: Previous sleep disturbance variables as standalone predictors. In this first step the 
longitudinal relationship between sleep and psychotic experiences was assessed by testing 
previous bad night sleep duration and sleep duration range as predictors of psychotic 
experiences at the next assessment time point in a linear mixed effects model.  
Step 2: Controlling for later sleep disturbance. In the second step the sleep variables at the later 
assessment time points were added to the model from Step 1. This allows a test of whether the 
previous sleep variables are significantly predictive of later psychotic experiences, once the 
expected relationship between sleep variables at the previous and later time points is controlled 
for.  
Step 3: Controlling for previous psychotic experience severity. In the final step previous 
psychotic experience severity was added to the model from Step 2. This tested if the coefficient 
of previous sleep disturbance continued to be significant when accounting for the expected 
relationship between previous and current psychotic experiences (as for the expected 
relationship between previous and current sleep as tested in Step 2).  
2.3.3 Hypothesis 3: Shorter ‘Bad night’ sleep duration and wider sleep duration range 
will be associated with increased depression and reduced quality of life 
A cross-sectional linear mixed effects model (similar to Hypothesis 1) was fitted to depression 
(BDI-PC) and quality of life (MANSA) outcomes . 
 9 
3 Results 
3.1 Demographic and descriptive data 
Demographic information for the study group can be found in Table 1. The group was 
predominantly male (n=98, 61.1%), and the average age was 20.7 years. The majority were 
white (n=147, 91.8%). The study group was balanced between interventions (n=80, 50%, in 
each group). 
Descriptive statistics for all the study variables can be found in Table 2. There was a general 
improvement in sleep over the study period: bad night sleep duration slightly increased, and the 
sleep duration range decreased. Bad night sleep duration was significantly negatively correlated 
with sleep duration range (r=-0.756, p<0.001). There was also a general improvement in 
psychotic experience severity and distress across the study, and in depression and quality of 
life.  
There were several significant differences in outcomes between the treatment groups, as can be 
seen in Table 3. The cognitive therapy group had lower severity in the Unusual Thought Content 
and Perceptual Abnormality dimensions of the CAARMS than those who received monitoring 
alone. The group receiving cognitive therapy also had a significantly narrower range of sleep 
duration (p=0.004), and showed a trend level significance for longer bad night sleep duration 
(p=0.067). No other significant differences were found between the treatment groups. 
3.2 Relationship between sleep and psychotic experiences  
3.2.1 Hypothesis one: a cross sectional model 
The results from this analysis are summarised in Table 4. Shorter bad night sleep duration was 
significantly associated with increased severity of non-bizarre ideas (NBI), perceptual 
abnormalities (PA), and psychotic experience distress. Narrower range of sleep duration was 
significantly related to increased severity of NBI. No significant relationships between bad night 
sleep duration or sleep duration range were found for either unusual thought content (UTC) or 
disorganised speech (DS) in this cross-sectional model.  
In summary, a shorter bad night sleep duration was cross-sectionally associated with increased 
delusional ideas and hallucinations (and distress) as hypothesised. However, narrower sleep 
range was significantly related to increased severity of delusional ideas, contrary to our 
hypothesis. 
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3.2.2 Hypothesis two: Longitudinal models 
Step 1: A longitudinal model. The results from this analysis are summarised in Table 5. The 
longitudinal relationships were similar to those in the cross-sectional model in that there were 
significant relationships between previous shorter bad night sleep duration and increased 
severity of later NBI and PA, although the relationship with distress did not reach significance 
when tested longitudinally (p=0.078). Smaller sleep duration range at the previous time point 
was significantly related to increased severity of later NBI. No significant relationships were 
found between the previous sleep variables and later UTC or DS.  
These results suggest that shorter bad night sleep duration is a significant predictor of later 
delusional ideas and hallucinations. Narrower sleep range was associated with increased 
severity of later delusional ideas, again contrary to hypothesis.  
Step 2: A longitudinal model controlling for later sleep. The results from this analysis can be 
found in Table 6. Previous short bad night sleep duration remained a significant predictor for 
later NBI, even once sleep at the later time point was controlled for. However, neither bad sleep 
duration nor sleep duration range (at either the previous or later time point) had a significant 
predictive effect on other psychotic experience severities.  
These findings suggest that the relationship between previous sleep disturbance and later 
hallucinations may be accounted for previous sleep disturbance predicting later sleep 
disturbance. However, previous bad night sleep duration was still a significant additional 
predictor of later delusional ideas, even once sleep disturbance at the later time point was 
accounted for.  
Step 3: A longitudinal model controlling for previous psychotic experience severity. Table 7 
shows the results from this phase of analysis. In all cases the previous severity of each psychotic 
experience is a significant positive predictor of later severity of that psychotic experience. The 
only sleep relationship remaining significant in these final models is a cross-sectional 
relationship between shorter bad night sleep and more severe NBI. No previous sleep 
disturbance variables remained significant predictors once previous psychotic experiences 
were accounted for.  
This final set of models therefore suggest that previous psychotic experience is a stronger 
predictor than previous sleep disturbance for later psychotic experiences, with no evidence of a 
unique contribution of sleep disturbance across time for predicting change in psychotic 
experiences.  
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3.2.3 Hypothesis three: sleep and psychological wellbeing 
The outcome of this stage of analysis can be seen in Table 8. Neither bad night sleep duration, 
nor sleep duration range, were significantly associated with depression or quality of life in these 
cross-sectional models. 
4 Discussion 
The aim of this study was to utilise a large dataset to perform an opportunistic investigation of 
the relationship between sleep duration and psychotic experiences in patients at high risk of 
psychosis. As hypothesised, shorter sleep duration on bad nights was cross-sectionally 
associated with significantly more delusional ideas and hallucinations, and with higher levels of 
distress from psychotic experiences. However, a smaller sleep duration range was associated 
with more severe delusional ideas, contrary to the hypothesised positive association. Similar 
relationships were present longitudinally, with shorter bad night sleep duration at the previous 
time point predicting later severity of hallucinations and delusional ideas, as hypothesised. 
However, when additional controls were added these relationships did not remain significant. 
Overall the results support further investigation in to the relationship between sleep 
disturbance and individual psychotic experiences.  
The significant associations between reduced bad night sleep duration and increased delusional 
ideas and hallucinations in the present study are consistent with the links between reduced 
sleep and increased paranoia and hallucinations as reported in a previous experimental study 
(Reeve et al., 2017). The association between narrower range and increased psychotic 
experiences was contrary to the study hypothesis, and appears inconsistent with previous 
studies that have reported a link between increased sleep variability and psychotic experiences 
(Lunsford-Avery et al., 2016; Waters et al., 2011). However, in the context of the bad night sleep 
duration results the most consistent interpretation is that overall low sleep duration (i.e. short 
sleep on good and bad nights) is associated with more severe psychotic experiences.  
These findings are consistent with theoretical models for sleep disruption and psychosis in the 
at-risk group. In one model sleep/wake disturbances are seen as both reflecting an underlying 
biological vulnerability and as an additional stressor. In other words, sleep disturbances are 
thought to initiate a vicious cycle wherein disrupted sleep leads to increased psychotic 
experiences, the distress from which disrupts sleep further (Lunsford-Avery and Mittal, 2013). 
It is also worth noting that participants who received the cognitive therapy intervention showed 
more improvement in sleep over the study period (as well as significantly less severe psychotic 
experiences). This supports a parallel between improving psychotic experiences and improved 
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sleep, which could be investigated more directly with a sleep intervention study. A recent pilot 
case series with an at-risk population indicated that treating sleep problems did result in 
decreases in psychotic experiences and negative affect (Bradley et al., 2018). Sleep treatment 
therefore represents an exciting new possibility for at-risk intervention.  
No significant relationships were found between the sleep variables and the psychotic 
experience dimensions of unusual thought content or disorganised speech, which indicates that 
the relationship between sleep disturbance and psychotic experiences may be somewhat 
selective, as has been reported elsewhere (Reeve et al., 2017). The findings from this study 
further support the importance of measuring individual psychotic experiences separately when 
investigating the influence of sleep.  
The non-significant relationship between depression and either measure of sleep disturbance in 
the results is surprising. This is contrary to previous findings indicating negative affect as a 
mediator in the sleep disturbance and psychosis relationship (e.g. Reeve et al., 2017), and 
contrary to a general literature linking sleep disturbance with depression (Murphy and 
Peterson, 2015). The BDI-PC scale used in the current study is typically used as a screening tool 
with a categorical outcome (with scores ≥ 4 indicating major depression). Notably, the majority 
of the participants were above this cut-off throughout the trial. Nevertheless, as these scores 
were  used dimensionally, this measure may have lacked sensitivity to detect changes. The null 
relationship between sleep and quality of life is also unexpected. Sleep problems reduce quality 
of life (Kyle et al., 2010a, 2010b), and sleep and quality of life have both been linked to psychotic 
symptoms in clinical groups (Afonso et al., 2011). A potential explanation could be that fatigue 
is more linked than sleep to functional health (Waters et al., 2013), however as there is no 
measure of fatigue in the current study it was not possible to assess this. The null finding in both 
depression and quality of life could also be related to lower power in these tests, given the lower 
rate of completion of these measures.  
One worthwhile issue to investigate is whether disrupted sleep is associated with transition to 
psychosis. This was not possible to test in this study as there was a very low transition rate to 
psychosis in the group (9.4%), lower than expected in a group of individuals fulfilling the at-risk 
criteria (typically >16%; Hartmann et al., 2016; Yung et al., 2008). This transition rate could 
have been lower due to a positive effect of the study monitoring on improving psychotic 
experiences. Indeed, as can be seen in the descriptive measures both study groups showed 
improvements in severity of psychotic experiences and other measures over time.  
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4.1 Limitations 
Similar to previous large studies from the at-risk literature (Miller et al., 2003; Poe et al., 2017; 
Ruhrmann et al., 2010), the EDIE-2 study did not have sleep as a focus. However, one advantage 
of the current study is that the sleep information is not a single sleep quality judgement as in the 
SAPS, but gives duration information. It is also worth noting that youth at risk of psychosis have 
elsewhere been found to be accurate self reporters of sleep duration (Lunsford-Avery et al., 
2015). Secondly, in this study sleep information was collected at up to nine time points over two 
years. As a result, this goes beyond previous secondary analysis studies where sleep 
information was only collected at a maximum of two time points.  
The sleep duration estimates have some limitations as measures of sleep disturbance. For 
example, the frequency of good nights versus bad nights was not assessed, which would have 
allowed calculation of an average sleep time and variability of sleep. The duration variable also 
does not give context on the timing of sleep, which is important as circadian dysfunction is 
commonly reported in individuals with psychosis (Wulff et al., 2012), and has been found to be 
predictive of positive symptoms in individuals at risk of psychosis (Lunsford-Avery et al., 2016).  
One limitation in the statistical approach is co-linearity amongst the predictors. The two sleep 
variables were negatively correlated, such that individuals with shorter bad sleep duration had 
a wider sleep duration range (as would be expected within a common insomnia presentation). 
Sleep variables were also highly correlated over time. This decreases the possibility that 
individual variables will emerge as predictors of variance in the outcome (i.e. psychotic 
experience severity). One way to reduce this effect is to mean centre the variables within each 
participant. However, in the present study differences between the starting position for each 
participant is non-arbitrary (e.g. a change from 8 hours to 6 hours sleep on a bad night is 
unlikely to have the same effect as a change from 6 hours to 4 hours), therefore this option was 
not appropriate. Another way to remove this issue is to induce changes in the predictor variable 
across time (e.g. by providing an intervention), as in the pilot trial recently reported by Bradley 
and colleagues (2017).  
A separate statistical limitation in this study is the need to control for site and treatment 
allocation, which will have reduced the power available to detect other effects in the remaining 
variance. This may have contributed to the low significance of the relationships reported, which 
in many cases would not survive conservative corrections for multiple testing. However, given 
that the approach here is of planned comparisons, where all analyses are pre-specified, it is not 
necessarily appropriate to apply these corrections (Feise, 2002; Schulz and Grimes, 2005). 
Furthermore, it was not possible to control for age or occupational status, which are likely to be 
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a source of significant variance in sleep as reported in the current study. Substance abuse was 
also not accounted for in the current study.  
Overall the findings show that sleep disturbance, even when indirectly measured, acts as a 
significant longitudinal predictor of later psychotic experiences in the at-risk population (up 
until the most conservative corrections are made). Prediction of clinical trajectories is 
particularly valuable for the at-risk group, therefore a possible role of sleep disturbance in 
predicting later outcomes deserves further investigation. This study also supports the potential 
importance of treating sleep disturbance in this group, a possibility now beginning to be 
explored in the clinical literature (Bradley et al., 2018). Future studies should investigate the 
effectiveness of these interventions on psychotic symptoms, and assess sleep disorder 
symptoms in clinical groups in order to refine intervention targets.  
  
Figures 
Figure 1: Analysis plan diagram 
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Tables 
Table 1: Demographics 
Age – mean (SD) 20.9 (4.2) 
Gender - n (%)  
Male 98 (61.1) 
Female 62 (38.9) 
Ethnicity - n (%)  
White 147 (91.8) 
Black (African/Caribbean/British/Other) 6 (3.8) 
Asian (Indian/Pakistani/British/Chinese/Other) 3 (1.9) 
Other 4 (2.5) 
Randomisation – n (%)  
Monitoring + cognitive therapy 80 (50.0) 
Monitoring only 80 (50.0) 
  
Table 2: Descriptive statistics for the study measures 
 Baseline 3 months 6 months 9 months 12 months 15 months 18 months 21 months 24 months 
 Mean (SD) N Mean (SD) N Mean (SD) N Mean (SD) N Mean (SD) N Mean (SD) N Mean (SD) N Mean (SD) N Mean (SD) N 
Sleep duration (hours) 
‘Good’ 8.28 (2.5) 153 8.24 (2.2) 103 8.01 (2.2) 92 8.30 (2.4) 91 8.23 (2.2) 94 8.32 (2.3) 57 7.79 (2.5) 47 8.37 (2.0) 41 7.65 (1.6) 37 
‘Bad’ 4.14 (3.4) 136 4.54 (2.8) 96 4.81 (3.3) 90 4.58 (2.7) 88 4.45 (2.9) 91 5.27 (3.4) 52 4.94 (3.8) 40 5.49 (3.6) 40 4.99 (3.5) 36 
Range 4.01 (3.6) 136 3.65 (3.1) 96 3.29 (3.1) 89 3.76 (3.4) 88 3.82 (3.3) 90 3.07 (3.4) 52 2.89 (4.5) 40 2.90 (3.5) 39 2.73 (3.0) 35 
CAARMS dimensions 
UTC 8.26 (7.7) 160 3.91 (6.5) 119 3.69 (6.0) 115 3.49 (6.4) 105 3.93 (6.9) 109 3.06 (5.7) 65 3.09 (6.6) 55 2.65 (4.8) 48 2.00 (4.5) 43 
NBI 13.58 (7.1) 160 7.05 (7.4) 119 6.04 (6.8) 115 5.79 (6.9) 105 6.30 (8.0) 109 6.20 (6.9) 65 5.07 (6.7) 55 6.40 (7.4) 48 6.93 (9.0) 43 
PA 10.11 (7.1) 160 5.49 (6.1) 119 4.72 (6.1) 115 4.79 (5.6) 106 4.90 (6.6) 108 4.23 (6.0) 65 4.25 (6.6) 55 4.54 (7.5) 48 5.16 (7.5) 43 
DS 4.23 (4.8) 160 2.73 (4.1) 119 2.10 (3.6) 115 2.44 (4.0) 105 3.41 (4.8) 109 2.52 (4.1) 65 2.51 (3.4) 55 3.06 (4.7) 48 4.37 (6.9) 43 
Distress 
43.19 
(20.8) 
153 
23.41 
(22.1) 
111 
18.81 
(20.9) 
111 
19.78 
(20.4) 
103 
19.53 
(17.9) 
105 
18.86 
(21.3) 
63 16.09 (19.2) 54 19.36 (22.6) 48 
18.89 
(21.3) 
40 
Wellbeing 
MANSA 50.3 (10.7) 122   
54.98 
(11.7) 
84   
56.42 
(13.3) 
84         
BDI-PC 10.16 (4.4) 148   6.25 (4.6) 108   6.63 (5.2) 103         
 
CAARMS = Comprehensive Assessment of At Risk Mental States; UTC=Unusual Thought Content; NBI = Non-Bizarre Ideas; PA = Perceptual Abnormalities; DS = 
Disorganised Speech; BDI-PC – Beck Depression Inventory for Primary Care; MANSA = Manchester Short Assessment of Quality of Life 
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Table 3: Comparison between treatment groups on sleep, psychotic experiences, and 
wellbeing (all time points except baseline) 
 Group means (SD) Independent samples t-test 
 Monitoring only Monitoring and CBT t-value p-value 
Sleep 
BadDur 4.53 (3.3) 5.03 (3.0) -1.84 0.067 
Range 3.82 (3.5) 2.97 (3.1) 2.93 0.004 
CAARMS dimensions 
Distress 19.24 (20.0) 17.33 (19.0) 1.53 0.127 
UTC 4.73 (7.5) 3.39 (5.9) 3.15 0.002 
NBI 6.66 (7.9) 6.28 (7.5) 0.78 0.435 
PA 5.13 (6.5) 4.06 (5.7) 2.82 0.005 
DS 3.38 (5.0) 3.26 (4.8) 0.39 0.696 
Wellbeing 
MANSA 58.28 (12.6) 56.34 (13.3) 1.19 0.237 
BDI-PC 5.55 (4.8) 5.62 (4.9) -0.14 0.889 
BadDur = Bad night sleep duration (hours) 
Range = Sleep duration range (hours) 
Data included from all time points except baseline
  
Table 4: Mixed effect model output – hypothesis one (cross-sectional only) 
BadDur = Bad night sleep duration (hours) 
Range = Sleep duration range (hours) 
Treatment allocation and site controlled for in all analyses  
 
Factor Estimate Std. Error df t p 
95% confidence interval 
Lower bound Upper bound 
Unusual thought content BadDur -0.059 0.11 541.9 -0.52 0.602 -0.28 0.16 
Range -0.010 0.11 583.8 -0.09 0.926 -0.23 0.21 
Non-bizarre ideas BadDur -0.402 0.14 610.3 -2.88 0.004 -0.68 -0.13 
Range -0.331 0.13 578.0 -2.53 0.012 -0.59 -0.07 
Perceptual abnormalities BadDur -0.327 0.13 615.7 -2.59 0.010 -0.57 -0.08 
Range 0.003 0.12 600.2 0.02 0.983 -0.23 0.24 
Disorganised speech BadDur -0.041 0.08 612.5 -0.53 0.596 -0.19 0.11 
Range 0.026 0.07 586.5 0.36 0.719 -0.12 0.17 
Distress BadDur -1.170 0.42 589.8 -2.79 0.005 -1.99 -0.35 
Range -0.415 0.39 566.1 -1.07 0.287 -1.18 0.35 
  
Table 5: Mixed effect model output – hypothesis two (step one -without current sleep control)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BadDur = Bad night sleep duration (hours) 
Range = Sleep duration range (hours) 
t-1 = from previous time point 
Treatment allocation and site controlled for in all analyses  
 
 
 
Factor Estimate Std. Error df t p 
95% Confidence 
Interval 
Lower Upper 
Psychotic Experiences (CAARMS) 
Unusual thought content t-1_BadDur -0.167 0.13 464.5 -1.31 0.190 -0.42 0.08 
t-1_Range -0.154 0.12 446.4 -1.28 0.202 -0.39 0.08 
Non-bizarre ideas t-1_BadDur -0.432 0.15 440.7 -2.96 0.003 -0.72 -0.14 
t-1_Range -0.281 0.14 393.7 -2.07 0.039 -0.55 -0.01 
Perceptual abnormalities t-1_BadDur -0.324 0.14 467.5 -2.39 0.017 -0.59 -0.06 
t-1_Range 0.009 0.13 458.6 0.07 0.947 -0.24 0.26 
Disorganised speech t-1_BadDur -0.116 0.09 465.9 -1.35 0.178 -0.29 0.05 
t-1_Range 0.005 0.08 437.3 0.06 0.954 -0.15 0.16 
Distress t-1_BadDur -0.812 0.46 469.8 -1.77 0.078 -1.71 0.09 
t-1_Range -0.369 0.43 444.2 -0.86 0.389 -1.21 0.47 
  
Table 6: Mixed effect model output – hypothesis two (step two - with current sleep control) 
 
Factor Estimate Std. Error df t p 
95% Confidence 
Interval 
 Lower Upper 
Unusual Thought Content BadDur -0.052 0.15 327.9 -0.34 0.736 -0.36 0.25 
Range 0.005 0.14 395.2 0.04 0.971 -0.27 0.28 
t-1_BadDur  -0.132 0.15 341.1 -0.89 0.374 -0.42 0.16 
t-1_Range -0.106 0.14 381.0 -0.77 0.443 -0.38 0.17 
Non-Bizarre Ideas BadDur -0.384 0.18 368.9 -2.10 0.036 -0.74 -0.02 
Range -0.401 0.16 374.1 -2.51 0.012 -0.71 -0.09 
t-1_BadDur  -0.383 0.18 390.6 -2.18 0.030 -0.73 -0.04 
t-1_Range -0.193 0.16 372.8 -1.23 0.220 -0.50 0.12 
Perceptual Abnormalities BadDur -0.184 0.17 399.6 -1.06 0.291 -0.53 0.16 
Range 0.077 0.15 402.0 0.51 0.613 -0.22 0.38 
t-1_BadDur  -0.259 0.17 409.4 -1.56 0.121 -0.59 0.07 
t-1_Range 0.018 0.15 397.0 0.12 0.902 -0.28 0.31 
Disorganised Speech BadDur -0.052 0.11 402.8 -0.47 0.637 -0.27 0.16 
Range  0.002 0.09 369.8 0.02 0.986 -0.18 0.19 
t-1_BadDur  -0.030 0.11 414.4 -0.29 0.775 -0.24 0.18 
t-1_Range 0.062 0.09 379.8 0.67 0.503 -0.12 0.25 
Distress BadDur -1.080 0.58 386.5 -1.87 0.062 -2.22 0.05 
Range -0.409 0.49 373.4 -0.83 0.406 -1.37 0.56 
t-1_BadDur  -0.146 0.54 393.9 -0.27 0.788 -1.22 0.92 
t-1_Range 0.101 0.48 354.2 0.21 0.833 -0.84 1.04 
BadDur = Bad night sleep duration (hours) 
Range = Sleep duration range (hours) 
t-1 = from previous time point 
Treatment allocation and site controlled for in all analyses  
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Table 7: Mixed effect model output – hypothesis two (step three – with controls for current 
sleep and previous psychotic experience) 
 Factor Estimate Std. 
Error 
df t Sig 95% 
confidence 
interval 
Lower Upper 
Unusual Thought 
Content 
BadDur -0.121 0.14 332.3 -0.87 0.385 -0.39 0.15 
Range 0.009 0.12 351.0 0.07 0.944 -0.23 0.25 
t-1_BadDur  0.009 0.13 342.4 0.06 0.949 -0.25 0.27 
t-1_Range -0.031 0.12 357.1 -0.26 0.798 -0.27 0.21 
t-1_UTC 0.395 0.04 370.5 10.23 0.000 0.32 0.47 
Non-Bizarre 
Ideas 
BadDur -0.365 0.16 387.3 -2.28 0.023 -0.68 -0.05 
Range -0.226 0.14 369.3 -1.64 0.101 -0.50 0.04 
t-1_BadDur  -0.036 0.15 397.9 -0.23 0.816 -0.34 0.27 
t-1_Range -0.059 0.13 355.2 -0.43 0.664 -0.32 0.21 
t-1_NBI 0.477 0.04 389.5 12.59 0.000 0.40 0.55 
Perceptual 
Abnormalities 
BadDur -0.181 0.16 402.4 -1.14 0.256 -0.49 0.13 
Range 0.070 0.14 386.9 0.51 0.614 -0.20 0.34 
t-1_BadDur  -0.082 0.15 404.3 -0.54 0.589 -0.38 0.22 
t-1_Range -0.032 0.14 386.2 -0.23 0.815 -0.30 0.23 
t-1_PA 0.406 0.04 401.4 9.88 0.000 0.33 0.49 
Disorganised 
Speech 
BadDur -0.051 0.11 399.6 -0.48 0.629 -0.26 0.16 
Range -0.013 0.09 354.9 -0.15 0.883 -0.19 0.17 
t-1_BadDur  -0.011 0.10 413.0 -0.11 0.911 -0.21 0.19 
t-1_Range 0.034 0.09 375.7 0.38 0.703 -0.14 0.21 
t-1_DS 0.286 0.05 381.5 6.25 0.000 0.20 0.38 
Distress BadDur -1.158 0.60 371.5 -1.92 0.056 -2.35 0.03 
Range -0.424 0.50 349.7 -0.84 0.400 -1.41 0.57 
t-1_BadDur  -0.037 0.57 377.3 -0.07 0.948 -1.15 1.08 
t-1_Range 0.194 0.49 332.1 0.40 0.691 -0.76 1.15 
t-1_Distress 0.032 0.01 83.4 2.36 0.020 0.01 0.06 
BadDur = Bad night sleep duration (hours) 
Range = Sleep duration range (hours) 
t-1 = from previous time point 
Treatment allocation and site controlled for in all analyses  
 
  
Table 8: Mixed effect model output – hypothesis three (cross-sectional, depression and quality of life) 
 
 
 
 
BadDur = Bad night sleep duration (hours) 
Range = Sleep duration range (hours) 
Treatment allocation and site controlled for in all analyses  
BDI-PC – Beck Depression Inventory for Primary Care; MANSA = Manchester Short Assessment of Quality of Life 
 Factor Estimate Std. Error df t Sig 
95% confidence interval 
Lower 
bound 
Upper 
bound 
Depression (BDI-PC) BadDur -0.161 0.13 288.5 -1.21 0.226 -0.42 0.10 
 Range -0.013 0.13 289.4 -0.10 0.920 -0.26 0.24 
Quality of Life (MANSA) BadDur 0.332 0.34 224.3 0.98 0.330 -0.34 1.00 
Range 0.084 0.34 231.0 0.25 0.806 -0.59 0.76 
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